SCID

Nomenclature

CB17-Prkdcscid/Smoc

Cat. NO.

SM-015

Strain State

Repository Live

Export PDF

Model Description

SCID mice, or severe combined immunodeficiency mice, were first identified in 1983 by Bosma M.J. in the United States from the C.B.-17/Icr inbred strain. This condition arises from a mutation in a single recessive gene located on chromosome 16, also termed the SCID gene. SCID mice constitute an inbred homozygous line of C.B-17/IcrJ, exhibiting white coat colouration. This strain displays severe combined immunodeficiency, characterised by the absence of B-cell and T-lymphocyte function. Most homozygotes lack detectable levels of IgM, IgG1, IgG2a, IgG2b, IgG3, or IgA, and their thymus, lymph nodes, and splenic follicles contain almost no lymphocytes. However, the strain possesses normal NK cells, macrophages, and granulocytes. SCID mice are frequently used for inoculation with allogeneic or xenogeneic grafts, making them an ideal model for cell transplantation experiments.

Validation Data

image.png

Fig 1. Growth curve of SCID mice (n=460).

image.png

Fig 2. Hematological analysis of SCID mice.

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more